← Back to Discover
SMA Capital LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $238,090,420
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- AMETEK INC · COM · 031100100 · shares: $14,516,400
- IDEX CORP · COM · 45167R104 · shares: $11,801,400
- PARKER HANNIFIN CORP · COM · 701094104 · shares: $10,759,320
- JOHNSON CONTROLS INTERNATION · SHS · G51502105 · shares: $8,182,160
- CRH PLC · ORD · G25508105 · shares: $7,704,000
- PACKAGING CORP OF AMERICA · COM · 695156109 · shares: $7,624,960
- HUNT (JB) TRANSPRT SVCS INC · COM · 445658107 · shares: $7,235,750
- ITT INC · COM · 45073V108 · shares: $7,119,360
- TELEDYNE TECHNOLOGIES INC · COM · 879360105 · shares: $6,669,000
- CSX CORP · COM · 126408103 · shares: $6,654,200
Reported holdings
121 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 287 shares | $11,107 |
| OCULAR THERAPEUTIX INC | COM | 67576A100 | — | 1,098 shares | $10,782 |
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | — | 110 shares | $10,723 |
| TARSUS PHARMACEUTICALS INC | COM | 87650L103 | — | 169 shares | $10,637 |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | — | 173 shares | $10,442 |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | — | 387 shares | $10,441 |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | — | 412 shares | $10,424 |
| ERASCA INC | COM | 29479A108 | — | 569 shares | $10,424 |
| ARCUS BIOSCIENCES INC | COM | 03969F109 | — | 338 shares | $10,421 |
| ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | — | 485 shares | $10,403 |
| ALKERMES PLC | SHS | G01767105 | — | 198 shares | $10,374 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 204 shares | $10,353 |
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | — | 310 shares | $10,351 |
| CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | — | 278 shares | $10,344 |
| RELAY THERAPEUTICS INC | COM | 75943R102 | — | 552 shares | $10,328 |
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | — | 84 shares | $10,297 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | — | 239 shares | $10,255 |
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | — | 252 shares | $10,239 |
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | — | 92 shares | $10,215 |
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | — | 87 shares | $10,185 |
| SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | — | 216 shares | $10,046 |